Michael Yee

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Michael Yee works at JEFFERIES and is focused on Healthcare, Industrials sectors with 696 price targets and ratings documented since 2008 spanning on 26 stocks. Analyst's average stock valuation to be materialised ratio is 54.62% with an average time for price targets to be met of 186.38 days.

Most recent stock forecast was given on ESPR, Esperion Therapeutics, Inc at 24-Feb-2023.

Michael Yee best performing recommendations are on ALGS.
The best stock recommendation documented was for MRNA (MODERNA, INC) at 7/13/2020. The price target of $90 was fulfilled within 4 days with a profit of $18.22 (25.38%) receiving and performance score of 63.46.

Average potential price target upside

Currently, out of the existing stock ratings of Michael Yee - 33547 which are a Buy (78.57%), 8907 which are a Hold (20.86%), 244 which are a Sell (0.57%)

ACOR ADGI ALGS AMRN ASMB EPZM ESPR GILD ICPT MRNA PRTA SDGR AMGN VRTX AXON BIIB BMRN CELG CERE FGEN ONCE ODT ZLAB SRRK VTYX NUVB

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

35

$34.42 (5934.48%)

180

2 years 2 months 16 days ago

1/4 (25%)

$98.09 (180.48%)

205

Hold

6

$5.42 (934.48%)

42

2 years 10 months 23 days ago

6/8 (75%)

$11.62 (54.29%)

37

Hold

6

$5.42 (934.48%)

150

2 years 10 months 23 days ago

9/9 (100%)

$18.43 (16.56%)

274

Sell

6

$5.42 (934.48%)

60

3 years 5 months 8 days ago

7/7 (100%)

$-23.57 (-27.41%)

161

Hold

192

$191.42 (33003.45%)

222

4 years 6 months 18 days ago

1/3 (33.33%)

$51.7 (39.70%)

28

Show more analysts
ACOR ADGI ALGS AMRN ASMB EPZM ESPR GILD ICPT MRNA PRTA SDGR AMGN VRTX AXON BIIB BMRN CELG CERE FGEN ONCE ODT ZLAB SRRK VTYX NUVB